Begin your TipRanks Premium journey today. Cencora (COR) Company Description: Cencora, Inc. engages provision of pharmaceutical products and business solutions that improve access to care.

Shares of Cencora (COR) have been strong performers ... One industry peer that looks good is Medpace Holdings, Inc. (MEDP). MEDP has a Zacks Rank of # 2 (Buy) and a Value Score of C, a Growth ...

Shares of Cencora (COR) have been strong performers lately, with the stock up 13.4% over the past month. The stock hit a new 52-week high of $256.81 in the previous session. Cencora has gained 13.5% ...

Begin your TipRanks Premium journey today. Cencora (COR) Company Description: Cencora, Inc. engages provision of pharmaceutical products and business solutions that improve access to care.

Shares of Cencora (COR) have been strong performers lately, with the stock up 13.4% over the past month. The stock hit a new 52-week high of $256.81 in the previous session. Cencora has gained 13. ...

We recently published a list of Jim Cramer’s Latest Calls: 10 Stocks to Buy or Sell. In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against other stocks ...

Cencora COR underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light on ...

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments.

Cencora, Inc. (NYSE:COR), a $47.7 billion market cap leader in the wholesale drug distribution industry, disclosed today that two of its long-standing board members, Richard W. Gochnauer and Kathleen ...

Cencora, Inc. (NYSE:COR), a $47.7 billion market cap leader in the wholesale drug distribution industry, disclosed today that two of its long-standing board members, Richard W. Gochnauer and ...